|Articles|June 1, 2012
- BioPharm International-06-01-2012
- Volume 25
- Issue 6
BioPharm International, June 2012 Issue (PDF)
Celebrating 25 Years of BioPharma Innovation
Advertisement
Articles in this issue
over 13 years ago
Back-to-Basics with PDUFA Vover 13 years ago
Determining Process Quality Metrics for CMOsover 13 years ago
New Biopharmaceuticalsover 13 years ago
Reducing Human Errorover 13 years ago
Know the Regulationsover 13 years ago
Creating a Product Portfolio from the Ground Upover 13 years ago
25 Years of Nanoparticles: A Look Forwardover 13 years ago
25 Years of BioPharma Industry Growthover 13 years ago
Developing Alternatives to ELISA-Based Biomarker AssaysNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
